Aura 2016 Supplementary data

Table S4.10 Neisseria gonorrhoeae decreased susceptibility and resistance, 2000–14

Year	Number of isolates tested	Ceftriaxone decreased susceptibility, % (n)	Ciprofloxacin resistance, % (n)	Azithromycin resistance, % (n)	Penicillin resistance, % (n)
2000	3468	na	18.0 (619)	na	20.0 (679)
2001	3641	na	17.0 (638)	na	23.0 (832)
2002	3861	0.5 (21)	10.0 (389)	na	18.0 (695)
2003	3677	0.3 (10)	13.0 (452)	na	17.0 (639)
2004	3542	0.7 (24)	21.0 (757)	na	22.0 (770)
2005	3886	1.2 (48)	29.0 (1113)	na	30.0 (1148)
2006	3850	0.6 (23)	30.0 (1413)	na	34.0 (1306)
2007	3042	0.8 (25)	48.0 (1456)	na	38.0 (1163)
2008	3109	0.8 (25)	53.0 (1651)	na	44.0 (1367)
2009	3157	2.0 (64)	43.0 (1346)	1.1 (25)^a	36.0 (1142)
2010	3997	4.8 (192)	34.0 (1348)	1.1 (35)^a	29.0 (1161)
2011	4133	3.2 (134)	27.0 (1099)	1.5 (49)^a	26.0 (1053)
2012	4718	4.4 (207)	30.0 (1428)	1.3 (63)	32.0 (1513)
2013	4897	8.8 (429)^b	34.0 (1669)	2.1 (104)	35.0 (1700)
2014	4804	5.4 (258)	36.0 (1750)	2.5 (119)	29.0 (1370)

na = not available

a Excluding Victoria, as azithromycin data is not available

b An additional isolate from the Northern Territory had a minimum inhibitory concentration (MIC) of 0.5 mg/L to ceftriaxone, the highest recorded in Australia.

Note:

1. Decreased susceptibility to ceftriaxone: MIC 0.06–0.125 mg/L

2. Resistance to ciprofloxacin: MIC ≥1 mg/L

3. Resistance to azithromycin: MIC ≥1 mg/L

Source: NNN (Australian Gonococcal Surveillance Programme annual reports)

Table S4.11 Neisseria gonorrhoeae decreased susceptibility and resistance, by jurisdiction, 2014

Jurisdiction	Number of isolates tested	Ceftriaxone decreased susceptibility, % (n)	Ciprofloxacin resistance, % (n)	Azithromycin resistance, % (n)	Penicillin resistance, % (n)
ACT	75	2.7 (2)	44.0 (33)	9.3 (7)	12.0 (9)
NSW	1672	7.1 (119)	43.0 (726)	2.0 (33)	43.0 (725)
NT: urban and rural	99	3.0 (3)	27.0 (27)	0.0 (0)	21.0 (21)
NT: remote	130	0.8 (1)	3.1 (4)	0.0 (0)	1.5 (2)
Qld	650	3.2 (21)	28.0 (184)	3.5 (23)	24.0 (153)
SA	207	1.0 (2)	42.0 (86)	0.5 (1)	11.0 (22)
Tas	30	0.0 (0)	27.0 (8)	3.3 (1)	23.0 (7)
Vic	1440	6.6 (95)	39.0 (559)	2.3 (33)	22.0 (322)
WA: urban and rural	393	3.6 (14)	30.0 (117)	5.3 (21)	26.0 (104)
WA: remote	108	0.9 (1)	5.6 (6)	0.0 (0)	4.6 (5)
Australia	4804	5.4 (258)	36.0 (1750)	2.5 (119)	29.0 (1370)

ACT = Australian Capital Territory; NSW = New South Wales; NT = Northern Territory; Qld = Queensland; SA = South Australia; Tas = Tasmania; Vic = Victoria; WA = Western Australia

Note:

1. Decreased susceptibility to ceftriaxone: MIC 0.06–0.125 mg/L

2. Resistance to ciprofloxacin: MIC ≥1 mg/L

3. Resistance to azithromycin: MIC ≥1 mg/L

Source: NNN (Australian Gonococcal Surveillance Programme annual reports)